Share Issue News

QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH) (the “Company” or “Delcath”), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the Company granted equity awards, previously approved by the Company’s Compensation Committee, as material inducements to four individuals whose employment commenced in either November 2025 or December 2025. The grants, in the form of Restricted Stock Units (RSUs), totaled...

KELOWNA, British Columbia--(BUSINESS WIRE)--Kiboko Announces Effective Date of Share Consolidation...

BRUSSELS--(BUSINESS WIRE)--Regulatory News: Not to be published, distributed, released or disseminated, directly or indirectly, in or into the United States of America, Canada, Australia, South Africa or Japan, or any other jurisdiction in violation of the relevant laws of such jurisdiction. This press release is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy securities in any jurisdiction. Winamp Group SA (Euronext Growth Paris and...

MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia, fetal growth restriction and acute ischemic stroke, today announced that on January 15, 2026, it granted options to purchase an aggregate of 50,000 shares of DiaMedica’s common stock to a newly hired non-executive employee whose employment commenced in December 2025. The stock options were a material inducement to the emplo...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK; the “Company”) today announced that the company granted inducement equity awards covering an aggregate of 35,200 shares of its common stock to two newly hired employees, consisting of inducement stock options to purchase an aggregate of 20,400 shares of common stock and inducement restricted stock units, covering an aggregate of 14,800 shares of its common stock. The awards are subject to all terms and conditions and other provision...

LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to two new employees. On January 15, 2026, the Compensation Committee of Savara's Board of Directors granted the inducement awards to two new employees who recently joined the Company. The inducement awards consist of options to purchase an aggregate of 17,500 shares of the Company’s common stock and restrict...

BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. The Company today announced that, effective on January 15, 2026, it granted stock options to purchase an aggregate of 74,020 shares of common stock to nine...

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that on January 15, 2026, inducement grants (the “Inducement Grants”) were made to four employees in connection with the commencement of their employment. The Inducement Grants consist of 88,050 restricted stock units (“RSUs”) representing 88,050 shares of Quanterix common...

ORANGE COUNTY, Calif.--(BUSINESS WIRE)--Virgin Galactic Holdings, Inc. (NYSE: SPCE) (“Virgin Galactic”) announced that the Compensation Committee of Virgin Galactic’s Board of Directors approved the grants of time-based inducement restricted stock unit awards covering an aggregate of 42,339 shares of Virgin Galactic common stock to two new non-executive employees, each effective January 15, 2026. The awards were granted under Virgin Galactic’s Amended and Restated 2023 Employment Inducement Inc...

PAU, France--(BUSINESS WIRE)--Regulatory News: Arverne (FR001400JWR8 - ARVEN), the leading French supplier of geothermal solutions, publishes information relating to the total number of voting rights and the number of shares in its share capital at September 30, 2025, in accordance with the provisions of article R. 22-10-23 of the French Commercial Code. Date Total number of shares in the capital Total number of voting rights 12/31/2025 42 076 081 Number of theoretical voting rights: 42 076 081...